Nasal Endoscopic Surgery Beneficial for Chronic Sinusitis, Nasal Polyps
By Elana Gotkine HealthDay Reporter
TUESDAY, May 6, 2025 -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss compared with traditional open sinus surgery, according to a study published online April 18 in BMC Surgery.
Shengwei Chen, from the Otolaryngology Center of Shantou Chenghai District People's Hospital in China, and colleagues examined the efficacy of nasal endoscopic surgery in management of chronic sinusitis with nasal polyps. A total of 160 patients were included: 80 underwent endoscopic sinus surgery (study group) and 80 underwent traditional open sinus surgery (traditional surgery group). Surgical conditions, postoperative complications, recovery time, and postoperative pain scores were compared between the groups.
The researchers found that compared with the traditional surgery group, the study team had the procedure in less time, and they experienced less intraoperative blood loss. In terms of the overall incidence rate of postoperative adverse responses, the values in the study group were lower than those in the traditional surgery group. From before to after the operation, the grades of four aspects of quality of life improved in the two groups.
"Our study suggests that endoscopic sinus surgery has advantages over conventional open sinus surgery in terms of reduced operative time, intraoperative blood loss, and postoperative complications," the authors write. "However, these two different surgical techniques should be interpreted with caution when comparing them because they have different surgical goals and approaches."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Low Rates of Isolated Locoregional Recurrence Seen in Young Women With Breast Cancer
TUESDAY, July 29, 2025 -- For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer (BC) risk of 35 percent...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.